Early tests of a potential COVID-19 vaccine have shown promising results against the deadly virus, Queensland researchers say.
In preclinical tests, the University of Queensland’s COVID-19 vaccine has shown it can raise high levels of antibodies that can neutralise the virus.
The university’s project co-leader Professor Paul Young said the results were an excellent indication the vaccine worked as expected.
“This is what we were hoping for, and it’s a great relief for the team given the tremendous faith placed in our technology by CEPI (Coalition for Epidemic Preparedness Innovation), federal and Queensland governments and our philanthropic partners,” Prof Young said in a statement on Wednesday.
“We were particularly pleased that the strength of the antibody response was even better than those observed in samples from COVID-19 recovered patients.”
Dutch company Viroclinics Xplore is also collaborating on the vaccine tests.
Joint UQ project leader Dr Keith Chappell said the team had decided early on that ensuring a robust package of pre-clinical and safety data was critical before initiating a clinical trial.